1 / 9

Stem cell cartilage regeneration market analysis

Stem cell cartilage regeneration market analysis

rishabhCMI
Download Presentation

Stem cell cartilage regeneration market analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. STEM CELL CARTILAGE REGENERATION MARKET ANALYSIS • Stem Cell Cartilage Regeneration Market, by Stem Cell Type (Hematopoietic Stem Cells, Pluripotent Stem Cells, and Mesenchymal Stem Cells), by Treatment (Microfracture, Osteochondral Transplant, Autologous Chondrocyte Implantation, and Others), by End User (Hospitals & Clinics and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  3. Increasing adoption of minimally invasive surgery procedures is expected to drive growth of stem cell cartilage regeneration market. Stem cell therapy for knees, minimally invasive procedure has the potential to decrease inflammation, halt progression of arthritic damage, repair joint cartilage, and delay or avoid knee replacement surgery. Injection of progenitor cells, especially mesenchymal stem cells (MSCs) is found to be an effective and better solution for repairing degenerative cartilage compared to implantation of differentiated cells such as articular cartilage. • Increasing epidemic of osteoarthritis among the global population is expected to increase adoption of efficient and promising treatment such as stem cell therapy during the forecast period. For instance, according to the data findings published by Arthritis Foundation in November 2017, arthritis was the leading cause of disability among adults in the U.S. Over 53 million adults worldwide suffered from arthritis, which refers to over 100 types of joint diseases. This is expected to increase 49% to reach over 78.4 million by 2040. • The global stem cell cartilage regeneration market is estimated to be valued at US$ 298.3 million in 2019, and is expected to exhibit a CAGR of 9.1% over the forecast period (2020-2027).

  4. Stem Cell Cartilage Regeneration Market - Regional Insights • On the basis of region, the global stem cell cartilage regeneration market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the most lucrative region for growth of the stem cell cartilage regeneration market over the forecast period, due to high presence of key players in the region. Key players such as Vericel Corporation, Osiris Therapeutics, among others are focusing on various growth strategies such as gaining regulatory product approvals and launching innovative stem cell-based cartilage regeneration products and technologies in the market. • Furthermore, increasing geriatric population, who are more prone to degenerative disorders such as osteoarthritis among the U.S. population, is further expected to propel growth of the stem cell cartilage regeneration market in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), July 2018 data findings, from 2013-2015, around 54.4 million U.S. adults (22.7% of total U.S. population) annually suffered from some form of arthritis such as rheumatoid arthritis, gout, lupus, or fibromyalgia. • Asia Pacific stem cell cartilage regeneration market revenue is expected to witness significant growth over the forecast period. In India, stem cell-based cartilage regeneration procedures are conducted by various hospital and clinics. Moreover, hospitals such as Apollo, TOSH (Trauma & OrthopaedicSpeciality Hospital), among others are conducting stem cell-based knee arthritis surgery procedures

  5. Global Stem Cell Cartilage Regeneration Market - Competitive Landscape • Major players operating in the global stem cell cartilage regeneration market include Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation.

  6. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference: https://www.coherentmarketinsights.com/market-insight/stem-cell-cartilage-regeneration-market-2448

  7. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  8. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  9. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related